Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2003 Canadian hypertension recommendations. It's not all old hat.

× No keyword cloud information.

8 in total

1. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors: E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

Review 2. A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors: K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal: Can J Cardiol Date: 2000-09 Impact factor: 5.223

3. The 2001 Canadian Hypertension Recommendations--What is new and what is old but still important.

Authors: Norman R C Campbell
Journal: Can J Cardiol Date: 2002-06 Impact factor: 5.223

4. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

5. Awareness, treatment, and control of hypertension in Canada.

Authors: M R Joffres; P Ghadirian; J G Fodor; A Petrasovits; A Chockalingam; P Hamet
Journal: Am J Hypertens Date: 1997-10 Impact factor: 2.689

6. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors: B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

7. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors: Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal: N Engl J Med Date: 2003-02-13 Impact factor: 91.245

8. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal: Lancet Date: 2002-03-23 Impact factor: 79.321

8 in total